Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial
Improving Goals of Care Conversations With Hematopoietic Cell Transplant Survivors (IMPACT - HCT)
3 other identifiers
interventional
40
1 country
1
Brief Summary
This clinical trial evaluates the impact of patient navigation and the Planning Advance Care Together (PACT) website, either alone or in combination with one another, on advanced care planning (ACP) in patients with blood cancers who received a hematopoietic cell transplant (HCT). Engagement in ACP, including having goals of care conversations, improves quality of care at the end of life and supporting this should be included in all cancer survivorship care. Patient navigation is a healthcare service that is designed to guide a patient through the healthcare system and reduce barriers to timely screening follow-up, diagnosis, treatment, and supportive care. PACT is a web-based tool that provides information about ACP, assistance with documents for advanced directives, a supportive network and a forum for discussions about ACP. Patients who engage in ACP are more likely to have higher quality of life at the end of life, receive the care they want, die where they prefer, utilize hospice effectively, and are less likely to receive futile, aggressive care at the end of life. For HCT survivors at ongoing risk of death and other disease-related complications, having a plan in place for care they want is critical. Patient navigation and/or the PACT website may improve ACP, including completion of advance care directives and goals of care conversations, in patients with blood cancers who received an HCT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 4, 2025
CompletedStudy Start
First participant enrolled
October 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
April 24, 2026
April 1, 2026
7 months
June 24, 2025
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Feasibility (Rate of enrollment)
Descriptive statistics will be run, including means and standard deviations for continuous data and frequencies and proportions for categorical data. Feasibility cutoffs will be based on prior research and include \>= 50% of eligible patients will enroll in the study.
At baseline
Feasibility (Rate of completion of intervention components)
For the patient navigation component, this means that patients participate in the single patient navigation session with a health coach. For the Planning Advance Care Together (PACT) condition, this means that patients set up an account with the PACT website and engage in at least accessing the website. Feasibility cutoffs will be based on prior research and include \>= 50% of enrolled patients will adhere to and complete assigned intervention components and study-related assessments.
At 12 weeks post intervention
Feasibility (Rate of completion of study assessments)
Descriptive statistics will be run, including means and standard deviations for continuous data and frequencies and proportions for categorical data. Feasibility cutoffs will be based on prior research and include \>= 50% of enrolled patients will adhere to and complete assigned intervention components and study-related assessments.
At baseline, and at 4 and 12 weeks post intervention
Acceptability of intervention
Will be measured using the 4-item Acceptability of Intervention Measure. Items are rated on a 5-point Likert scale. Acceptability will be defined as a median score of \>= 4.
At 4 weeks post intervention
Completion of advance directives
Questions asking patients whether they have completed a do not resuscitate (DNR) order, living will or identified a health care proxy. This item is scored as having no advance directives (0) to all advance directives completed (3). In addition to the primary outcome of advance directives (0 to 3 score), investigators will also examine each outcome separately (e.g., yes/no to completing a health care proxy) as secondary measures.
At baseline, and at 4 and 12 weeks post intervention
Secondary Outcomes (7)
Discussion of advance care planning (ACP)/goals of care conversation
At baseline, and at 4 and 12 weeks post intervention
Level of engagement in ACP
At baseline, and at 4 and 12 weeks post intervention
Readiness to engage in ACP
At baseline, and at 4 and 12 weeks post intervention
Self-efficacy for treatment decision-making
At baseline, and at 4 and 12 weeks post intervention
Psychological distress
At baseline, and at 4 and 12 weeks post intervention
- +2 more secondary outcomes
Study Arms (4)
Condition 1 (PACT, patient navigation)
EXPERIMENTALPatients interact with the PACT website over 4 weeks and receive a navigation session over 45-60 minutes with a trained health coach to review ACP.
Condition 2 (patient navigation)
EXPERIMENTALPatients receive a navigation session over 45-60 minutes with a trained health coach to review ACP.
Condition 3 (PACT)
EXPERIMENTALPatients interact with the PACT website over 4 weeks.
Condition 4 (standard/usual care)
ACTIVE COMPARATORPatients receive standard/usual care for 4 weeks on study.
Interventions
Interact with PACT website
Receive a patient navigation session
Receive standard/usual care
Ancillary studies
Eligibility Criteria
You may qualify if:
- Received a transplant for a hematologic malignancy
- Current age 18 years of age or older
- Currently 1 to 5 years after HCT
- Ability to speak and read English
- Has not completed all advance directives and/or had a goals of care (GOC) conversation with their physician
- Access to the internet (via computer, tablet, or mobile device)
You may not qualify if:
- Unable to provide informed consent
- Uncontrolled psychiatric conditions (confirmed through electronic health record \[EHR\] by study staff)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Megan Shen, PhD
Fred Hutch/University of Washington Cancer Consortium
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2025
First Posted
July 4, 2025
Study Start
October 21, 2025
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share